The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment - Wikidata - awgldk - TriplyDB

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

http://www.wikidata.org/entity/Q34605896

about

Today and future of age-related macular degeneration Mechanisms of age-related macular degeneration Rapamycin reverses paraquat-induced acute lung injury in a rat model through inhibition of NFκB activation Platelet-derived growth factor (PDGF)-C inhibits neuroretinal apoptosis in a murine model of focal retinal degeneration.Insensitivity of PI3K/Akt/GSK3 signaling in peripheral blood mononuclear cells of age-related macular degeneration patients.Overstimulation can create health problems due to increases in PI3K/Akt/GSK3 insensitivity and GSK3 activity.Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration Generation and characterization of a murine model of Bietti crystalline dystrophy Transcriptome changes in age-related macular degeneration.Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.Inflammatory cytokines protect retinal pigment epithelial cells from oxidative stress-induced death.Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization.Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration.Vitamin D: Implications for ocular disease and therapeutic potential Nanoengineering of therapeutics for retinal vascular disease.Matrix γ-carboxyglutamate protein and Fetuin-A, in wet type age-related macular degeneration Macrophage polarization in the maculae of age-related macular degeneration: a pilot study Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells.Fluorocoxib A enables targeted detection of cyclooxygenase-2 in laser-induced choroidal neovascularization.Inflammatory Cytokines Induce Expression of Chemokines by Human Retinal Cells: Role in Chemokine Receptor Mediated Age-related Macular Degeneration A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization NLRP3 Upregulation in Retinal Pigment Epithelium in Age-Related Macular Degeneration Assessment of polygenic effects links primary open-angle glaucoma and age-related macular degeneration.Rat retinal transcriptome: effects of aging and AMD-like retinopathy Pigment epithelium-derived factor reduces apoptosis and pro-inflammatory cytokine gene expression in a murine model of focal retinal degeneration.Common coding variants in the HLA-DQB1 region confer susceptibility to age-related macular degeneration.Pro-inflammatory and anti-angiogenic effects of bisphosphonates on human cultured retinal pigment epithelial cells.Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration.Mechanism of inflammation in age-related macular degeneration Topical nonsteroidal anti-inflammatory drugs for macular edema.Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders.A Proinflammatory Function of Toll-Like Receptor 2 in the Retinal Pigment Epithelium as a Novel Target for Reducing Choroidal Neovascularization in Age-Related Macular Degeneration.Cytotoxicity considerations and electrically tunable release of dexamethasone from polypyrrole for the treatment of back-of-the-eye conditions.Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells Drusen and Pro-inflammatory Mediators in the Post-Mortem Human Eye.Is Spectral-Domain Optical Coherence Tomography Always Able to Detect the Anti-Vascular Endothelial Growth Factor Action on Neovascular Membrane?Combinatorial treatment with topical NSAIDs and anti-VEGF for age-related macular degeneration, a meta-analysis.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.TAK1 is involved in the autophagy process in retinal pigment epithelial cells.Optical Coherence Tomography Angiography to Distinguish Changes of Choroidal Neovascularization after Anti-VEGF Therapy: Monthly Loading Dose versus Pro Re Nata Regimen.

P2860

Q26865643-8AD8E5F6-BC3F-441D-A07D-4217D140379D Q27000182-B82C4F15-2177-44BA-BD39-8EF09FBC70E5 Q28383433-A222E002-7F57-437F-98EF-E022D186672E Q33690414-1F464631-8B60-4D96-BDF9-A3084A7EED50 Q33768692-5344A8D8-9747-4171-A1F5-5A4E0E2FF38D Q33984107-037B37F0-6429-4B18-B9FD-D048EBCD0235 Q34127531-D0029F92-97C8-43E7-A803-A6BDEA834CCD Q34159536-235BE2B1-0A5F-4990-810B-0BA5A8E82769 Q34174002-A2159572-F929-4654-809F-B1C5D72120F0 Q34530196-122D2F1A-A45E-4C5F-ACB3-7CDE8D99C9AF Q34738110-F25F8C5D-809C-4816-8935-F67D75759B23 Q34909956-31D757C7-B08F-4262-A0CD-C443A4175E4A Q34961356-D6909F44-268D-44BC-AB8F-11EDECF7EAF3 Q35588916-DF970CE5-5682-4195-BFB6-0DA5418E8CBE Q35645705-E3DF4080-CFA0-4AE5-A032-64AC2D751128 Q35691938-A1DD68A7-EF97-48D2-883A-5264B91595F4 Q35799329-855621C0-0BA1-46F6-B942-B0E6F1575D32 Q35974464-82A56566-7479-4140-B536-03B4C479A314 Q36132441-27E4F249-7875-4734-85FC-F89B9C62F6A8 Q36314850-208AC5CA-30A5-476C-91C1-11BB9B0ED0CD Q36319263-730A7AB3-7E2D-49D1-A8F7-3F14EC2D6AAE Q36512570-9C1A2B34-6563-4B4A-A02D-C10EF3D731C8 Q36949631-84608899-4712-41F8-9BC4-09CF12BDF7BF Q37018247-539B1964-70CA-4E5E-8DD0-B456CF3FF177 Q37342795-9CADC2A0-1BB0-4D5E-9B27-AEC9E7F2839C Q37351470-67586969-085E-4F49-98D1-8B2691480925 Q37626356-53939B45-0AD7-4196-B1AB-DBEA4B59A986 Q37626384-45AE29C0-34D5-4DC4-82D1-93FE08AF08B2 Q38064846-EFB40381-DEDD-4D6A-B013-DC1D0D9ED841 Q38162433-59F0B8C1-B867-464A-9F5B-794BDDF39219 Q38397111-EECB9C7E-2B3B-48A1-8A96-DCC384EAE2F5 Q38663964-F46E4643-5EAE-4FA6-B588-68DBFBC822B5 Q38906809-ECD8135B-60B8-4852-9EE8-1A8F49878604 Q41194130-6E3AF41B-F106-4B44-AE9D-386F86AFC385 Q41298547-451E42F6-7FDD-458D-A25B-2EE98AA6A847 Q41898073-73693759-CFF5-4D00-BD1A-DFC912C27F78 Q42371399-87950692-5634-4FAC-9ECB-EFCD9A107B63 Q47442388-FC6BD7EF-E39A-4CA0-B71E-FE402AFD9158 Q50428786-FCC2206F-AEBE-4FA3-A089-CBE701FFC787 Q53839618-CF6FAD2E-E06B-46DC-A6CE-06E9728EAD56

P2860

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

http://www.wikidata.org/entity/Q34605896

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

@ast

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

@en

The role of anti-inflammatory agents in age-related macular degeneration

@nl

type

label

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

@ast

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

@en

The role of anti-inflammatory agents in age-related macular degeneration

@nl

prefLabel

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

@ast

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

@en

The role of anti-inflammatory agents in age-related macular degeneration

@nl

P1433

Q34605896-E9F7A58A-2C4B-4964-866D-0D072D5C2009

P1476

Q34605896-7F757DB6-16A1-44CC-9313-4ECB32111CB5

P2093

Q34605896-2B8C2791-DEAB-4D77-AAC1-9D2E8A7FFAD1

Q34605896-3374103F-B671-46E8-84E1-2DF1143987B1

Q34605896-8ABD632B-9C60-4FAE-A2EF-E0D5910F1D14

P2860

Q34605896-02DDFEEF-6468-4D22-B2EA-5166A1A5130B

Q34605896-057EC293-14EB-4A84-A1F9-D55CC052CF1A

Q34605896-084EA432-DCA1-4FAD-80C8-85A22A112F16

Q34605896-109A2647-4BAD-44B8-A23B-D66194205864

Q34605896-154CBAE0-307C-45C9-BB73-8B9F4F86526A

Q34605896-19181207-62A9-4B93-B3ED-95D387073560

Q34605896-1923ED93-F51D-4375-90D8-DDA668D5FE67

Q34605896-1D0D051A-5773-4849-A1EC-EC7B7B285E5B

Q34605896-2388964B-7AAE-4200-88CA-B46C1FCE12F7

Q34605896-23AD370E-7833-4FDE-B135-AD61557D881D

P2888

Q34605896-5B6BB207-9D11-4154-B9C3-C785FF0033FB

P304

Q34605896-87EE7000-7FF1-4F0D-9F86-B040BFCF518B

P31

Q34605896-09eb8237-e076-461d-af55-b19a33a517a1

Q34605896-285384DE-F7FE-4D60-92E9-C2E48CFD9567

P356

Q34605896-4268AB57-4A69-4EB7-B76C-6E63A22FEAC8

P433

Q34605896-AFD5C2BA-DAA1-4B5C-84E4-91571F0A3347

P478

Q34605896-948EB47C-ED58-4B8C-8413-C0B992A2083B

P577

Q34605896-B6EEE106-3D73-4960-9D22-3DA21778202A

P5875

Q34605896-E8BE994A-701F-4570-BE35-314AFC0F3C2C

P6179

Q34605896-4645B673-47FF-404E-8984-2C34B0866C0C

P698

Q34605896-F091054D-EE37-4A40-9E0A-584E1F9F2699

P921

Q34605896-10490B33-6C47-4875-A15E-0FED147BBD1A

P932

Q34605896-0C748AC1-D247-441F-AB9B-88433BC4CF84

P356

P1433

P1476

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

@en

P2093

C-C Chan

http://www.w3.org/2001/XMLSchema#string

V M Wang

http://www.w3.org/2001/XMLSchema#string

Y Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Complement factor H polymorphism in age-related macular degeneration

Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635].

TOR, a central controller of cell growth.

Prevalence of age-related macular degeneration in the United States

Cyclooxygenases 1 and 2

Regulation of translation initiation by FRAP/mTOR

Photodynamic therapy with and without adjunctive intravitreal triamcinolone acetonide: a retrospective comparative study.

Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.

Estimation of systemic complement C3 activity in age-related macular degeneration.

Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.

P2888

P304

127-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EYE.2010.196

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49707602

http://www.w3.org/2001/XMLSchema#string

P6179

1051609150

http://www.w3.org/2001/XMLSchema#string

P698

21183941

http://www.w3.org/2001/XMLSchema#string

P921

P932

3044916

http://www.w3.org/2001/XMLSchema#string